Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
暂无分享，去创建一个
D. Tanné | K. Furie | C. Viscoli | W. Kernan | P. Peduzzi | R. Conwit | P. Guarino | L. Brass | J. Spence | M. Gorman | A. Carolei | M. Parsons | G. Ford | L. Young | S. Inzucchi | P. Ringleb | G. Schwartz | A. Lovejoy | Iris Investigators